More articles from Commentary * Commentaire

You have access
Oral isotretinoin: prescribers beware
N. H. Shear

CMAJ June 15, 1999 160 (12) 1723-1724;
You have access
Substitute decision-making for cognitively impaired older people
M. Brockett

CMAJ June 15, 1999 160 (12) 1721-1723;
You have access
The folly of population screening for type 2 diabetes
K. G. Marshall

CMAJ June 01, 1999 160 (11) 1592-1593;
You have access
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes
H. C. Gerstein and S. Meltzer

CMAJ June 01, 1999 160 (11) 1593-1595;
You have access
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes. Rebuttal to Marshall
H. C. Gerstein and S. Meltzer

CMAJ June 01, 1999 160 (11) 1596;
You have access
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes. Rebuttal to Gertstein and Meltzer
K. G. Marshall

CMAJ June 01, 1999 160 (11) 1595-1596;
You have access
Death provides renewed life for some, but ethical hazards for transplant teams
J. B. Dossetor

CMAJ June 01, 1999 160 (11) 1590-1591;
You have access
The price and challenges of extraordinary success: treating end-stage renal failure in the next milliennium
T. A. Hutchinson

CMAJ June 01, 1999 160 (11) 1589-1590;
You have access
The evolving paradigm of health technology assessment: reflections for the millennium
R. N. Battista and M. J. Hodge

CMAJ May 18, 1999 160 (10) 1464-1467;
You have access
Waiting lists for health care: A necessary evil?
R. F. Davies

CMAJ May 18, 1999 160 (10) 1469-1470;

Pages